Toripalimab With Chemotherapy for Sinus Cancer
Toripalimab With Chemotherapy for Sinus Cancer
Recruiting · NCT06940180 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Toripalimab With Chemotherapy for Sinus Cancer | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nose Neoplasms, Otorhinolaryngologic Neoplasms, carcinoma, epithelial neoplasm, nasal disorder, neoplasm, otorhinolaryngologic disease, paranasal sinus disorder, paranasal sinus neoplasm, respiratory system disorder, respiratory tract neoplasm, sinonasal undifferentiated carcinoma, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2026-08-31 | NCT06940180 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Coherus Oncology, Inc. | 14 |
| Dana-Farber Cancer Institute | 324 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 511 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |